During Episode 31 of Biotalk,Geoff Meyerson, CEO ofLocust Walk, explores Asia-Pacific biotech momentum across China, Japan, and Korea, as featured in our2025 Q3 Report: Global Trends in Biopharma T

During Episode 30 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q3 Report: Global Trends in Biopharma Transactions Report, covering capital markets, strategic deals, and regional tr

During the Asia-focused Episode 29 of Biotalk, Geoff shares insights into key trends and developments shaping the biotech landscapes in Japan, China, Korea, Australia, and the broader Asia-Pacific reg

During Episode 28 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q2 Report: Global Trends in Biopharma Transactions Report, covering capital markets, strategic deals, and regional tr

During Episode 27 of Biotalk, Geoff Meyerson, CEO of Locust Walk, steps back to examine the macro forces shaping the biopharma landscape. After holding a bearish outlook since 2021, Geoff explains why

During the Asia-focused Episode 26 of Biotalk, Geoff Meyerson, CEO ofLocust Walk, shares fresh insights from Japan, China, and Korea, as featured in our2025 Q1 Report: Global Trends in Biopharma Tra

During Episode 25 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q1 Report: Global Trends in Biopharma Transactions Report, covering capital markets, strategic deals, and regional tr